Wells Fargo Starts Estee Lauder (EL) at Outperform; Current Price Offers Investors Good Entry Point
Get Alerts EL Hot Sheet
Price: $86.10 -1.4%
Rating Summary:
20 Buy, 16 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
20 Buy, 16 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Wells Fargo initiates coverage on Estee Lauder (NYSE: EL) with an Outperform. PT range $59-62.
Analyst, Timothy Conder, said, "We view EL's deep and experienced management team as best in class among our beauty and personal care coverage. Organic sales growth will likely moderate in the next few years from unsustainable recession-recovery growth rates, but should still progress mid to high single digits as management strategically invests in the fastest-growing parts of the beauty industry: the travel retail channel and developing and emerging (D&E) markets including China and Brazil."
For an analyst ratings summary and ratings history on Estee Lauder click here. For more ratings news on Estee Lauder click here.
Shares of Estee Lauder closed at $56.15 yesterday.
Analyst, Timothy Conder, said, "We view EL's deep and experienced management team as best in class among our beauty and personal care coverage. Organic sales growth will likely moderate in the next few years from unsustainable recession-recovery growth rates, but should still progress mid to high single digits as management strategically invests in the fastest-growing parts of the beauty industry: the travel retail channel and developing and emerging (D&E) markets including China and Brazil."
For an analyst ratings summary and ratings history on Estee Lauder click here. For more ratings news on Estee Lauder click here.
Shares of Estee Lauder closed at $56.15 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'
- VICI Properties closes $1.75B senior unsecured notes offering
- Leerink Starts Ligand Pharma (LGND) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share